Reach First-in-Human Trials Faster

Quality, time and costs are critical factors when considering outsourcing. Selecting a trustworthy partner that offers comprehensive and scalable solutions allow sponsors greater control of programs, in addition to reducing time and costs. The need to partner with an integrated, start-to-finish CDMO is key to getting to the clinic faster and with less complexity. Read this playbook and gain insights into leveraging how people, technology, supply chain, and integration can help sponsors reach a successful First-in-Human study.?

There are a range of benefits to using an integrated supplier to streamline biologic drug development, starting in early phase development through clinical and commercial stages. In this article, Catalent experts share examples where integrated drug product and clinical supply services enabled a client to expedite timelines and avoid costly errors.

Catalent Biologics state-of-the-art drug product facilities provide integrated solutions from early-phase development and small-scale manufacturing through to late-phase and commercial fill/finish and packaging. Catalent's experts simplify the path to tech transfer, reducing risks and accelerating programs through the clinic and to market. Whether you are developing new biological entities, biosimilars, or sterile injectables, we have the proven drug product experience to support your needs.